Super-Refractory Status Epilepticus: A Therapeutic Challenge in Paediatrics

Area of Science:

• Neurology
• Critical Care Medicine

Background:

• Super-Refractory Status Epilepticus (SRSE) is defined as status epilepticus persisting for ≥24 hours despite anesthesia or recurring upon its withdrawal.
• SRSE is a rare but critical medical emergency associated with substantial morbidity and mortality.
• Current management guidelines for SRSE are lacking, with limited literature primarily based on case reports and expert opinions.

Observation:

• Three pediatric cases (ages 6-7) with prior normal development presented with SRSE.
• Probable etiologies included viral meningoencephalitis, fever-induced refractory status epilepticus, and autoimmune encephalitis.
• Commonly used anesthetic agents were midazolam, pentobarbital, and ketamine, alongside antiepileptic drugs like phenytoin, phenobarbitone, valproate, and levetiracetam.

Findings:

• All three pediatric patients experienced significant therapeutic challenges due to SRSE.
• The cases resulted in residual neurological deficits and secondary morbidities such as pneumonia and sepsis.
• SRSE is associated with high rates of mortality and morbidity, underscoring the need for prompt intervention.

Implications:

• The management of SRSE remains a therapeutic challenge requiring immediate treatment strategies.
• Further research and clear clinical guidelines are essential for improving outcomes in SRSE patients.
• Understanding the diverse etiologies and complications of SRSE is crucial for effective patient care.